Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Therapeutic Advances in Medical Oncology|December 20, 2019
NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cellsNaomi C Bosch, Reinhard E Voll, Caroline J Voskens, et al.
Journal of Immunotoxicology|February 12, 2014
Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cellsLorenz Kulzer, Yvonne Rubner, Lisa Deloch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturationNiels Schaft, Jan Dörrie, Peter Thumann, et al.
The Journal of Pathology|July 23, 2025
Enhanced diagnostic potential of CSPG4 in melanoma and nevi: a comparative study with PRAME, CDC7 and Ki67Elias At Koch, Christina Seidel, Ramona Erber, et al.
Frontiers in Oncology|August 6, 2025
Case Report: Personalized peptide-based immunization in an advanced-stage prostate cancer patient with bone metastasisNils Heinrich Thoennissen, Mari Carmen Martos-Contreras, Mehdi Manoochehri, et al.
International Journal of Molecular Sciences|August 15, 2018
The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of MelanomaBianca Simon, Manuel Wiesinger, Johannes März, et al.
Cells|June 25, 2025
Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory FashionDennis Christoph Harrer, Tim Schlierkamp-Voosen, Markus Barden, et al.
Frontiers in Immunology|June 28, 2024
Individualized neoantigen peptide immunization of a metastatic pancreatic cancer patient: a case report of combined tumor and liquid biopsyTim Roehnisch, Mari Carmen Martos-Contreras, Mehdi Manoochehri, et al.
Frontiers in Immunology|September 22, 2023
The future of affordable cancer immunotherapyNiels Schaft, Jan Dörrie, Gerold Schuler, et al.
European Journal of Immunology|August 8, 2014
Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapyIsabell A Pfeiffer, Stefanie Hoyer, Kerstin F Gerer, et al.
Pageof 9